Halozyme Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US40637H1095
USD
62.86
-0.57 (-0.9%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,396.61
1,015.32
829.25
660.12
443.31
267.59
195.99
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,396.61
1,015.32
829.25
660.12
443.31
267.59
195.99
Raw Material Cost
305.44
230.47
266.13
182.45
81.41
43.37
45.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
18.13
18.09
18.76
16.95
7.53
20.38
11.63
Selling and Distribution Expenses
193.39
154.34
149.18
121.63
50.32
45.74
63.49
Other Expenses
6.34
6.10
5.76
4.97
2.81
1.39
11.20
Total Expenditure (Excl Depreciation)
580.32
463.85
491.68
370.69
167.41
123.34
232.64
Operating Profit (PBDIT) excl Other Income
816.3
551.5
337.59999999999997
289.40000000000003
275.9
144.3
-36.7
Other Income
21.47
23.75
16.32
1.05
1.10
5.42
6.99
Operating Profit (PBDIT)
925.82
656.54
438.75
340.12
280.00
152.96
-25.60
Interest
18.13
18.09
18.76
16.95
7.53
20.38
11.63
Exceptional Items
-352.76
0.00
13.20
-24.61
-20.96
0.00
-30.96
Gross Profit (PBDT)
1,091.17
784.86
563.12
477.66
361.90
224.23
150.45
Depreciation
88.05
81.31
84.86
49.64
3.00
3.28
4.07
Profit Before Tax
466.88
557.13
348.33
248.92
248.52
129.30
-72.25
Tax
149.99
113.04
66.73
46.79
-154.19
0.22
-0.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
316.89
444.09
281.59
202.13
402.71
129.09
-72.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
316.89
444.09
281.59
202.13
402.71
129.09
-72.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
316.89
444.09
281.59
202.13
402.71
129.09
-72.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
48.81
363.82
83.81
169.80
196.95
151.05
91.77
Earnings per share (EPS)
2.56
3.43
2.1
1.44
2.74
0.91
-0.5
Diluted Earnings per share
2.56
3.43
2.1
1.44
2.74
0.91
-0.5
Operating Profit Margin (Excl OI)
58.45%
54.32%
40.71%
43.85%
62.24%
53.91%
-18.7%
Gross Profit Margin
39.73%
62.88%
52.24%
45.23%
56.74%
49.55%
-34.79%
PAT Margin
22.69%
43.74%
33.96%
30.62%
90.84%
48.24%
-36.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 37.56% vs 22.43% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -28.64% vs 57.71% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 42.90% vs 49.81% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 0.00% vs -3.72% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Halozyme Therapeutics, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,396.61
4,715.00
-3,318.39
-70.38%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,396.61
4,715.00
-3,318.39
-70.38%
Raw Material Cost
305.44
2,665.00
-2,359.56
-88.54%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
18.13
300.00
-281.87
-93.96%
Selling and Distribution Expenses
193.39
1,430.00
-1,236.61
-86.48%
Other Expenses
6.34
6.80
-0.46
-6.76%
Total Expenditure (Excl Depreciation)
580.32
4,463.00
-3,882.68
-87.00%
Operating Profit (PBDIT) excl Other Income
816.29
252.00
564.29
223.92%
Other Income
21.47
27.00
-5.53
-20.48%
Operating Profit (PBDIT)
925.82
959.00
-33.18
-3.46%
Interest
18.13
300.00
-281.87
-93.96%
Exceptional Items
-352.76
-203.00
-149.76
-73.77%
Gross Profit (PBDT)
1,091.17
2,050.00
-958.83
-46.77%
Depreciation
88.05
680.00
-591.95
-87.05%
Profit Before Tax
466.88
-224.00
690.88
308.43%
Tax
149.99
8.00
141.99
1,774.88%
Provisions and contingencies
0
0
0.00
Profit After Tax
316.89
-232.00
548.89
236.59%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
316.89
-232.00
548.89
236.59%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
316.89
-232.00
548.89
236.59%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
48.81
6,547.00
-6,498.19
-99.25%
Earnings per share (EPS)
2.56
-0.47
3.03
644.68%
Diluted Earnings per share
2.56
-0.47
3.03
644.68%
Operating Profit Margin (Excl OI)
58.45%
5.34%
0.00
53.11%
Gross Profit Margin
39.73%
9.67%
0.00
30.06%
PAT Margin
22.69%
-4.92%
0.00
27.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 139.66 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 37.56% vs 22.43% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 31.69 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -28.64% vs 57.71% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 90.43 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 42.90% vs 49.81% in Dec 2024

Annual - Interest
Interest 1.81 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.00% vs -3.72% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 58.45%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024